This is a continuation of a Program Project Grant on basic and clinical studies related to osteoporosis. It includes an administrative core, molecular histology and transgenic animal core laboratories, and four major projects. The projects are 1) studies on the effects of sex hormones on bone formation and prostaglandin production, 2) studies on the role of glucocorticoids on collagen gene expression, 3) the development of new transgenic models to assess the hormonal and constitutive regulation of bone matrix synthesis in vivo and 4) studies on the effect of sex hormones on cytokine production and osteoclast formation and function. These projects will be closely integrated with other ongoing research efforts in bone metabolism currently being carried out at the University of Connecticut Health Center and its affiliated institutions, including laboratory studies and clinical research in the General Clinical Research Center (GCRC) and the Osteoporosis Center. The existence of a Program Project is osteoporosis has been vital in generating new research interactions among the many faculty involved in studies on bone and connective tissue metabolism and musculoskeletal disease at this institution. It has led to new initiatives in the application of molecular biology and genetic techniques to the pathogenesis of osteoporosis. Future interactions in the Program Project Grant should help us to provide new knowledge and lead to a better understanding of pathogenesis and more effective approaches to prediction, prevention and therapy in osteoporosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Program Projects (P01)
Project #
2P01AR038933-06
Application #
3092398
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Project Start
1987-09-30
Project End
1996-08-31
Budget Start
1992-09-30
Budget End
1993-08-31
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Connecticut
Department
Type
Schools of Medicine
DUNS #
City
Farmington
State
CT
Country
United States
Zip Code
06030
Marijanovic, Inga; Kronenberg, Mark S; Erceg Ivkosic, Ivana et al. (2009) Comparison of proliferation and differentiation of calvarial osteoblast cultures derived from Msx2 deficient and wild type mice. Coll Antropol 33:919-24
Zhang, W; Pantschenko, A G; McCarthy, M-B et al. (2007) Bone-targeted overexpression of Bcl-2 increases osteoblast adhesion and differentiation and inhibits mineralization in vitro. Calcif Tissue Int 80:111-22
He, Jianing; Rosen, Clifford J; Adams, Douglas J et al. (2006) Postnatal growth and bone mass in mice with IGF-I haploinsufficiency. Bone 38:826-35
Lengner, Christopher J; Steinman, Heather A; Gagnon, James et al. (2006) Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling. J Cell Biol 172:909-21
Delahunty, K M; Shultz, K L; Gronowicz, G A et al. (2006) Congenic mice provide in vivo evidence for a genetic locus that modulates serum insulin-like growth factor-I and bone acquisition. Endocrinology 147:3915-23
Sher, L B; Harrison, J R; Adams, D J et al. (2006) Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling. Calcif Tissue Int 79:118-25
Jiang, Jin; Lichtler, Alexander C; Gronowicz, Gloria A et al. (2006) Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling. Bone 39:494-504
Lee, Sun-Kyeong; Gardner, Amy E; Kalinowski, Judith F et al. (2006) RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production. Bone 38:678-85
Pantschenko, Alexander G; Zhang, Wenjian; Nahounou, Marcia et al. (2005) Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice. J Bone Miner Res 20:1414-29
Kim, Nacksung; Kadono, Yuho; Takami, Masamichi et al. (2005) Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med 202:589-95

Showing the most recent 10 out of 94 publications